Literature DB >> 17643332

Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations.

Elena Garrido1, Amparo Chabás, Maria Josep Coll, Mariana Blanco, Carmen Domínguez, Daniel Grinberg, Lluïsa Vilageliu, Bru Cormand.   

Abstract

Maroteaux-Lamy syndrome, or mucopolysaccharidosis VI (MPS VI), is an autosomal recessive lysosomal storage disorder caused by a deficiency of N-acetylgalactosamine-4-sulfatase or arylsulfatase B (ARSB). We aimed to analyze the spectrum of mutations responsible for the disorder in Spanish and Argentinian patients, not previously studied. We identified all the ARSB mutant alleles, nine of them novel, in 12 Spanish and 4 Argentinian patients. The new changes were as follows: six missense mutations: c.245T>G [p.L82R], c.413A>G [p.Y138C], c.719C>T [p.S240F], c.922G>A [p.G308R], c.1340G>T [p.C447F] and c.1415T>C [p.L472P]; one nonsense mutation: c.966G>A [p.W322X]; and two intronic changes involving splice sites: c.1142+2T>A, in the donor splice site of intron 5, which promotes skipping of exon 5, and c.1143-1G>C, which disrupts the acceptor site of intron 5, resulting in skipping of exon 6. We also report 10 previously described mutations as well as several non-pathogenic polymorphisms. Haplotype analysis indicated a common origin for most of the mutations found more than once. Most of the patients were compound heterozygotes, whereas only four of them were homozygous. These observations confirm the broad allelic heterogeneity of the disease, with 19 different mutations in 16 patients. However, the two most frequent mutations, c.1143-1G>C and c.1143-8T>G, present in both populations, accounted for one-third of the mutant alleles in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643332     DOI: 10.1016/j.ymgme.2007.06.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux-Lamy Syndrome.

Authors:  M Pineda; M O'Callaghan; A Fernandez Lopez; M J Coll; R Ullot; G Garcia-Fructuoso
Journal:  JIMD Rep       Date:  2016-02-27

2.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

3.  Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI.

Authors:  Rokhsareh Jafaryazdi; Sedigheh Shams; Anna Isaian; Aria Setoodeh; Shahram Teimourian
Journal:  Mol Biol Rep       Date:  2019-04-13       Impact factor: 2.316

4.  Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism.

Authors:  Alessandra Zanetti; Elena Ferraresi; Luigi Picci; Mirella Filocamo; Rossella Parini; Camillo Rosano; Rosella Tomanin; Maurizio Scarpa
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

5.  Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).

Authors:  Gustavo Adolfo Giraldo; Paola Ayala-Ramírez; Juan Carlos Prieto; Reggie García-Robles; Johanna Carolina Acosta
Journal:  Meta Gene       Date:  2015-12-23

6.  Mutational analysis of ARSB gene in mucopolysaccharidosis type VI: identification of three novel mutations in Iranian patients.

Authors:  Nasrin Malekpour; Rahim Vakili; Tayebeh Hamzehloie
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

7.  Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases.

Authors:  Marta Gómez-Grau; Elena Garrido; Mónica Cozar; Víctor Rodriguez-Sureda; Carmen Domínguez; Concepción Arenas; Richard A Gatti; Bru Cormand; Daniel Grinberg; Lluïsa Vilageliu
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

8.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17

9.  Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI.

Authors:  Anusha Uttarilli; Prajnya Ranganath; S Jamal Md Nurul Jain; C Krishna Prasad; Anupam Sinha; Ishwar C Verma; Shubha R Phadke; Ratna D Puri; Sumita Danda; Mamta N Muranjan; Ganesh Jevalikar; H A Nagarajaram; Ashwin B Dalal
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

10.  Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.

Authors:  Leslie A Lyons; Robert A Grahn; Francesca Genova; Michela Beccaglia; John J Hopwood; Maria Longeri
Journal:  BMC Vet Res       Date:  2016-07-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.